Advertisement

Angiogenesis pp 103-109 | Cite as

Interactions between Oxidized Lipoprotein (a) [Lp(a)], Monocytes and Endothelial Cells

  • Mahmoud Ragab
  • Periasamy Selvaraj
  • Demetrios S. Sgoutas
Chapter
Part of the NATO ASI Series book series (NSSA, volume 263)

Summary

Lipoprotein (a) [Lp(a)] is a subclass of low density lipoproteins (LDL) whose elevated blood concentrations constitute an independent risk factor for coronary artery disease (CAD). Lipoprotein (a) derives its uniqueness from an appendage, apolipoprotein (a), which is linked to the apolipoprotein B-100 portion of LDL. Apolipoprotein (a) has been found to display a remarkable homology with plasminogen. This homology has lead to suggestions that there may be competition between Lp(a) and plasminogen for binding to fibrin, and to cell membranes. Consequently, much attention has been paid to interactions between fibrin, Lp(a), and plasmin and to the linkage of thrombosis and atherogenesis.

In contrast, this study draws attention at the cholesterol rich component of Lp(a) which is identical to LDL, investigates its oxidation and the role of oxidized Lp(a) in activating resident intimai macrophages. It provides evidence that oxidatively modified Lp(a), enhanced the expression of surface antigens on U937 cells and stimulated adhesion of U937 cells to cultured endothelial cells. These results suggest that oxidatively modified Lp(a) like oxidized LDL behaves as an inducer of differentiation, adhesion and activation of monocytes, leading to the hypothesis that oxidized Lp(a) may play an important role in atherogenesis, and CAD.

Keywords

Endothelial Cell Fatty Acid Composition U937 Cell Clot Lysis U937 Monocytic Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Reidy, M.A., J. Fingerle, and V. Lindner, Factors controlling the development of arterial lesions after injury. Circulation, 1992. 86 (Suppl. III): p. 43.Google Scholar
  2. 2.
    Lerman, A. and J.C. Burnett, Jr., Intact and altered endothelium in regulation of vacsometion. Circulation, 1992. 86 (Suppl III): p. 12.Google Scholar
  3. 3.
    Schwartz, R.S., D.R. Holmes, and E.J. Topol, The restenosis paradigm revisited: an alternative proposal for cellular mechanism. J. Am. Coll. Cardiol., 1992. 20: p. 1284.PubMedCrossRefGoogle Scholar
  4. 4.
    Vlodaysky, L., et al., Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis. J. Cell. Biochem, 1991. 47: p. 167.CrossRefGoogle Scholar
  5. 5.
    Dahlen, G.H., et al., Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation, 1986. 74: p. 758.PubMedCrossRefGoogle Scholar
  6. 6.
    Hearn, J.A., et al., Predictive value of lipoprotein (a) and other serum lipoproteins in the angiographic diagnosis of coronary artery disease. Am. J. Cardiol., 1990. 66: p. 1176.PubMedCrossRefGoogle Scholar
  7. 7.
    Hearn, J.A., et al., Usefulness of serum lipoprotein (a) as a predictor of restensis after percutaneous coronary angioplasty. Am. J. Cardiol., 1992. 69: p. 736.PubMedCrossRefGoogle Scholar
  8. 8.
    Loscalzo, J., Lipoprotein (a): a unique risk factor for atherothrombotic disease. Arteriosclerosis, 1990. 10: p. 672.PubMedCrossRefGoogle Scholar
  9. 9.
    Loscalzo, J., et al., Lipoprotein (a), fibrin binding, and plasminogen activation. Arteriosclerosis, 1990. 10: p. 240.PubMedCrossRefGoogle Scholar
  10. 10.
    Utermann, G., The mysteries of lipoprotein (a). Science, 1989. 246: p. 904.PubMedCrossRefGoogle Scholar
  11. 11.
    Scanu, A.M., Lp(a): a link between thrombosis and atherosclerosis. Ear. J. Epidem., 1992. 8: p. 76.CrossRefGoogle Scholar
  12. 12.
    Hajjar, K.A., et al., Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature, 1989. 339: p. 303.PubMedCrossRefGoogle Scholar
  13. 13.
    Scanu, A.M. and G.M. Fless, Lipoprotein (a): heterogeneity and biological relevance. J. Clin. Invest., 1990. 85: p. 1709.PubMedCrossRefGoogle Scholar
  14. 14.
    Sattler, W., et al., Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins. Biochem. Biophys. Acta., 1991. 1081: p. 65.PubMedCrossRefGoogle Scholar
  15. 15.
    Naruszewicz, M., E. Selinger, and J. Davignon, Oxidative modification of lipoprotein (a) and the effect of b-carotein. Metabolism, 1992. 41: p. 1215.PubMedCrossRefGoogle Scholar
  16. 16.
    Parthasarathy, S., D. Steinberg, and J.L. Witztum, The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annual. Rev. Med., 1992. 43: p. 219.CrossRefGoogle Scholar
  17. 17.
    Esterbauer, H., et al., Continuous monitoring of ia vitro oxidation of human low density lipoproteins. Free Rad. Res. Commun., 1989. 6: p. 67.CrossRefGoogle Scholar
  18. 18.
    Frostegard, J., et al., Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc. Natl. Acad. Sci. U.S.A., 1990. 47: p. 904.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Mahmoud Ragab
    • 1
  • Periasamy Selvaraj
    • 1
  • Demetrios S. Sgoutas
    • 1
  1. 1.Department of Pathology and Laboratory MedicineEmory University School of MedicineAtlantaUSA

Personalised recommendations